Business
Medline Reports Fourth Quarter and Full Year 2025 Results
Delivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25
About this update from Medline Inc.
[{"type":"image","alt":"Medline Inc.","displaySize":"","headline":null,"caption":"Medline Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":158,"url":"https://media.zenfs.com/en/globenewswire.com/2d8c708a7ed51728be2cd85d36012fea"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.BxSgF_L39114WfXSxyYHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2d8c708a7ed51728be2cd85d36012fea","width":300,"height":158}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Delivered strong full year 2025 results","length":39,"tagName":"p"}]},{"val":[{"type":"text","content":"Completed Initial Public Offering","length":33,"tagName":"p"}]},{"val":[{"type":"text","content":"Introduced full year 2026 guidance","length":34,"tagName":"p"}]},{"val":[{"type":"text","content":"Fourth quarter net sales of $7.8 billion, an increase of 14.8%","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"Fourth quarter net income of $180 million, a decrease of 37.7%","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"Fourth quarter Adjusted EBITDA1 of $805 million, approximately flat","length":67,"tagName":"p"}]},{"val":[{"type":"text","content":"Full year net sales of $28.4 billion, an increase of 11.5%","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Full year net income of $1.2 billion, a decrease of 3.6%","length":56,"tagName":"p"}]},{"val":[{"type":"text","content":"Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2%","length":63,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":474,"olType":false},{"type":"text","content":"NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care2, today reported its operating results for the three months and full year ended December 31, 2025.","length":330,"tagName":"p"},{"type":"text","content":"“We delivered strong fourth quarter results, concluding a successful 2025 with $2.4 billion in total new customer signings3,” said Jim Boyle, Chief Executive Officer of Medline. “This performance reflects the confidence customers place in our value, service and reliability, and our unique capability to support health s...